# What This Senate Resolution Actually Says

This is a Senate resolution expressing support for the FDA's approval of mifepristone, a medication used for abortion, and calling for abortion access policies to be based on scientific evidence rather than other considerations. It's important to understand that this is a resolution—essentially a statement of the Senate's position—rather than a law that would directly change anything. Resolutions don't have the force of law, but they do signal what a chamber of Congress believes and can influence future policy discussions.

The resolution specifically says the Senate believes the FDA made the right call when it determined mifepristone is safe and effective for medical use. The FDA approved this medication in 2000, and it's been used by hundreds of thousands of people since then. The resolution argues that laws and policies about who can access this medication should be based on scientific research and medical evidence, not other factors. In practical terms, this means supporters of the resolution want abortion access decisions to follow what doctors and scientists say about safety and effectiveness, rather than being restricted by other types of regulations.

This matters because mifepristone access has become increasingly restricted in various states since the Supreme Court overturned the federal right to abortion in 2022. Some states have banned it entirely, while others have limited when and how it can be used. People who support this resolution believe those restrictions contradict what the scientific evidence shows about the medication's safety. People who oppose it generally believe states should have the power to restrict abortion access regardless of what the FDA says, or they have other moral or religious objections to abortion itself.

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Warren, Elizabeth

<p>This resolution expresses the sense of the Senate that (1) policies governing access to medication abortion care should be based on scientific review by the Food and Drug Administration (FDA), and (2) the FDA has found&nbsp;mifepristone to be safe and effective for women seeking abortions.</p>